Tetrazole compounds and their use as metabotropic glutamate receptor antagonits

Details for Australian Patent Application No. 2005214379 (hide)

Owner AstraZeneca AB

Inventors McLeod, Donald; Slassi, Abdelmalik; Wensbo, David; Edwards, Louise; Xin, Tao; Staaf, Karin; Minidis, Alexander; Isaac, Methvin; Johansson, Martin; O'Brien, Anne

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005214379

PCT Pub. Number WO2005/080356

Priority 60/545,291 18.02.04 US

Filing date 17 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 22 March 2012

International Classifications

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/080356 Priority application(s): WO2005/080356

13 December 2007 Assignment before Grant

  AstraZeneca AB; NPS Pharmaceuticals, Inc. The application has been assigned to AstraZeneca AB

22 March 2012 Application Accepted

  Published as AU-B-2005214379

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214380-Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders

2005214378-Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists